These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29229606)

  • 1. Coactivation of Estrogen Receptor and IKKβ Induces a Dormant Metastatic Phenotype in ER-Positive Breast Cancer.
    El-Shennawy L; Dubrovskyi O; Kastrati I; Danes JM; Zhang Y; Whiteley HE; Creighton CJ; Frasor J
    Cancer Res; 2018 Feb; 78(4):974-984. PubMed ID: 29229606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres.
    Kastrati I; Canestrari E; Frasor J
    Oncogene; 2015 Apr; 34(18):2309-16. PubMed ID: 24954507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
    Tian X; Zhang Z
    IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the Role of NFκB in Promoting Aggressive Phenotypes of Estrogen Receptor-Positive Breast Cancer.
    Smart E; Semina SE; Frasor J
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32887995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
    Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
    Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a metastatic hybrid cell line generated by ER negative and ER positive breast cancer cells in mouse bone marrow.
    Mukhopadhyay KD; Bandyopadhyay A; Chang TT; Elkahloun AG; Cornell JE; Yang J; Goins BA; Yeh IT; Sun LZ
    PLoS One; 2011; 6(6):e20473. PubMed ID: 21673810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils.
    Vazquez Rodriguez G; Abrahamsson A; Jensen LD; Dabrosin C
    Cancer Immunol Res; 2017 Mar; 5(3):234-247. PubMed ID: 28159748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome.
    West DC; Pan D; Tonsing-Carter EY; Hernandez KM; Pierce CF; Styke SC; Bowie KR; Garcia TI; Kocherginsky M; Conzen SD
    Mol Cancer Res; 2016 Aug; 14(8):707-19. PubMed ID: 27141101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence.
    Tivari S; Lu H; Dasgupta T; De Lorenzo MS; Wieder R
    Cell Commun Signal; 2018 Aug; 16(1):48. PubMed ID: 30119678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
    Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells.
    Planas-Silva MD; Waltz PK
    J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):11-21. PubMed ID: 17197171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer.
    Elsarraj HS; Valdez KE; Hong Y; Grimm SL; Ricci LR; Fan F; Tawfik O; May L; Cusick T; Inciardi M; Redick M; Gatewood J; Winblad O; Hilsenbeck S; Edwards DP; Hagan CR; Godwin AK; Fabian C; Behbod F
    Cancer Res; 2017 Jul; 77(14):3802-3813. PubMed ID: 28515148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer.
    Lee GA; Hwang KA; Choi KC
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
    Gökmen-Polar Y; Toroni RA; Hocevar BA; Badve S; Zhao Q; Shen C; Bruckheimer E; Kinch MS; Miller KD
    Breast Cancer Res Treat; 2011 Jun; 127(2):375-84. PubMed ID: 20602165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
    Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
    J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-tert-Octylphenol stimulates the expression of cathepsins in human breast cancer cells and xenografted breast tumors of a mouse model via an estrogen receptor-mediated signaling pathway.
    Lee HR; Choi KC
    Toxicology; 2013 Feb; 304():13-20. PubMed ID: 23219593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARD1 contributes to IKKβ-mediated breast cancer tumorigenesis.
    Zhang Y; Zhou H; Tao Y; Liu X; Yuan Z; Nie C
    Cell Death Dis; 2018 Aug; 9(9):860. PubMed ID: 30154412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.